Peptide University · Module 2 · Lesson 3 of 4

Half-life engineering

General pharmacology: pharmacodynamics and pharmacokinetics

Reading time: ~2 min · Part of the free certification in peptide science

Prolonging a peptide's t½ is an exercise in molecular design. Main strategies:

  • D-amino acids. Replacing an L residue with its D enantiomer at a cleavage point prevents recognition by stereospecific peptidases.
  • Acylation / lipidation. Anchoring a fatty acid chain that binds reversibly to albumin, creating a slow-release circulating depot. It is the mechanism of semaglutide (C18 fatty diacid) and of the long duration of tirzepatide.
  • PEGylation. Conjugating polyethylene glycol increases the hydrodynamic radius, reduces renal clearance and protects from proteases.
  • N-methylation and cyclization. They hinder enzymatic recognition and rigidify the active conformation.
  • Fusion to Fc or albumin: larger-scale strategies used in peptide-protein biopharmaceuticals.

The sermorelin → CJC-1295 pair illustrates the principle: both are GHRH analogs, but CJC-1295 incorporates substitutions that resist DPP-4 (and, in its DAC version, albumin binding), multiplying its duration of action. The pharmacokinetic lesson is constant: small sequence changes yield large changes in behavior, and those changes directly determine the dosing schedule.

Catalogue compounds mentioned in this lesson

Take the module 2 quiz and earn your certificate

The certification is free: read the lessons, pass each module quiz and the final exam, and download your PDF certificate with a verifiable ID.

Go to the quiz →

Educational content for scientific purposes. It distinguishes preclinical from clinical evidence and is not medical advice, diagnosis or a recommendation for use. NeoPeptidos products are sold labelled for research use only (RUO).